FDA recall D-0098-2018
Mayne Pharma Inc · Class II · drug
Product
Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC 0574-0222-01
Reason for recall
Failed Dissolution Specifications.
Distribution
Nationwide within USA
Key facts
- Status
- Terminated
- Initiation date
- 2017-11-09
- Report date
- 2017-12-06
- Termination date
- 2020-05-11
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Greenville, NC, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0098-2018